Citius Oncology Statistics

Total Valuation

CTOR has a market cap or net worth of $68.45 million.

Market Cap	68.45M
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Friday, February 21, 2025, before market open.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	n/a

Share Statistics

CTOR has 71.30 million shares outstanding.

Current Share Class	71.30M
Shares Outstanding	71.30M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.05%
Float	5.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.80
P/TBV Ratio	4.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.32

Current Ratio	0.32
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -85.28% and return on invested capital (ROIC) is -51.73%.

Return on Equity (ROE)	-85.28%
Return on Assets (ROA)	-24.23%
Return on Capital (ROIC)	-51.73%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CTOR has paid $576,000 in taxes.

Income Tax	576,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.21% in the last 52 weeks. The beta is -0.21, so CTOR's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-91.21%
50-Day Moving Average	1.13
200-Day Moving Average	7.40
Relative Strength Index (RSI)	42.26
Average Volume (20 Days)	5,697,126

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-18.95M
Pretax Income	n/a
Net Income	-19.52M
EBITDA	n/a
EBIT	-18.95M
Earnings Per Share (EPS)	-$0.29

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	17.03M
Book Value Per Share	0.25
Working Capital	-21.39M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTOR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-28.52%
FCF Yield	n/a

Analyst Forecast

The average price target for CTOR is $4.50, which is 368.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	368.75%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a